Sedentary Behavior in African Americans

Cardiovascular Disease Clinical Trial

— SeBA  

Official title:

Measurement of Sedentary Behavior in African American Adults

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00907465
• Other study ID #: PBRC 27013
• Secondary ID: 1K01HL088723-01
• Status: Completed
• Phase: N/A
• First received: May 18, 2009
• Last updated: December 2, 2012
• Start date: July 2007
• Est. completion date: October 2008

Study information

• Verified date: December 2012
• Source: Pennington Biomedical Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: National Institutes of Health
• Study type: Observational

Clinical Trial Summary

The study is designed to develop methods for objectively measuring sedentary behavior, assess the association between objectively measured sedentary behavior and cardiovascular disease outcomes, and develop an intervention to reduce sedentary behavior, in African American adults.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 25
• Est. completion date: October 2008
• Est. primary completion date: October 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• self-classify yourself as African American

• are aged 18 years or older

• are free of serious medical condition, such as cancer, cardiovascular disease, or emphysema.

• are free of serious medical conditions that would prevent participant from engaging in physical activity.

• are willing to have a scan completed that measures your body composition

• are willing to stay in metabolic chamber for 8.5 hours (8:00am until 4:30 pm)

• are willing to wear an accelerometer for 2, one-week periods following your chamber stay. There will be one week in-between the 2, one-week periods.

• are willing to complete questionnaire related to your level of activity

• weigh less than 250 lbs.

Exclusion Criteria:

• unwilling or unable to perform activities in protocol

• on medications

• a woman who is intending to become pregnant, or who is pregnant

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiovascular Disease
• Cardiovascular Diseases

Locations

Country	Name	City	State
United States	Pennington Biomedical Research Center	Baton Rouge	Louisiana

Sponsors (1)

Lead Sponsor	Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sedentary behavior		2009-2010	No
Secondary	Blood pressure		2009-2010	No
Secondary	High density lipoproteins		2009-2010	No